Market Pulse: U.S. stocks retreated yesterday, with the Dow industrials down 271.87 points, while the S&P 500 and Nasdaq edged lower by 0.37% and 0.33%, respectively (The Times of India).
Key Movers: Figma shares climbed after a better-than-expected earnings report (Figma shares climb on earnings beat, but analysts note that AI risk remains, CNBC), while Cenovus outperformed following its MEG acquisition boost (Cenovus earnings beat expectations as MEG acquisition boosts output, Financial Post). Walmart also topped forecasts but flagged an unstable backdrop (Walmart earnings beat estimates, but company offers cautious outlook amid ‘somewhat unstable' backdrop, Yahoo Entertainment).
Macro & Politics: Regulatory heat is rising: James Cameron warned of a “disastrous” Netflix–WBD tie-up (James Cameron Warns of ‘Disastrous’ Potential of Netflix-WBD Deal in Fiery Letter to Lawmaker, TheWrap), and a poll suggests Republicans risk a “devastating” midterm turnout if pro-life priorities are ignored (Republicans Risk ‘Devastating’ Midterm Turnout If Trump Admin Ignores Pro-Life Priorities, Poll Finds, The Daily Caller).
What’s Next: Watch short-interest in Hyperliquid and keep an eye on the FDA’s review of Moderna’s new flu shot for further volatility.
Market Commentary
Everyone’s yawning at yesterday’s index slump, but what they’re missing is the looming AI risk. Figma’s beat came with a cautionary caveat—analysts warn those bot engines may underdeliver (Figma shares climb on earnings beat, but analysts note that AI risk remains, CNBC). Underappreciated skeptics are stacking the bear case beneath the hype, and that’s the current driving force in tech.
When regulators flip on a dime, markets pay attention. The FDA’s about-face on Moderna’s new flu shot (In reversal, U.S. agrees to review new Moderna flu shot, Japan Today; FDA reverses course on Moderna flu shot, NPR) exposed how a single decision can unsettle biotech traders. Coupled with mounting political pressure—the Republican base warning of a “devastating” midterm turnout if pro-life priorities are sidelined (Republicans Risk ‘Devastating’ Midterm Turnout If Trump Admin Ignores Pro-Life Priorities, Poll Finds, The Daily Caller)—it’s a volatility cocktail few have fully digested.
Investors should tilt into high-beta squeezers and energy standouts. Keep a close watch on short-interest metrics in Hyperliquid (Hyperliquid tests $30: Will a squeeze trigger HYPE’s breakout?, Ambcrypto.com), and lean on Cenovus for a pullback play after its MEG acquisition boost (Cenovus earnings beat expectations as MEG acquisition boosts output, Financial Post). Position sizing and swift trades will separate the winners from the rest.
📈 Breaking Financial News
Hume Band 2026 Consumer Report: What Hume Health Discloses About “Metabolic Momentum,” Biological Age Metrics, and Longevity Tracking
Hume Health discloses Metabolic Momentum, biological age metrics, and longevity tracking features of the Hume Band wearable device in 2026….
Figma shares climb on earnings beat, but analysts note that AI risk remains
Figma's revenue grew 40% year over year to $303.8 million during the period.
Cenovus earnings beat expectations as MEG acquisition boosts output
Cenovus posted a sharp rise in profit as oilsands production was boosted by newly acquired MEG Energy assets. Read more
MemoTril (URGENT REPORT 2026) Introduced as a Brain Health Supplement in the Growing Cognitive Wellness Market
MemoTril is presented as a cognitive health dietary supplement that is in the growing cognitive wellness market. The release provides details of its type of ingredients, regulation, and consumer preference, and responsible consumption. MemoTril is presented a…
Walmart earnings beat estimates, but company offers cautious outlook amid ‘somewhat unstable' backdrop
Walmart reported results for its fiscal fourth quarter but chose to offer more conservative guidance for the year ahead.
One specific coin aligns perfectly with Trump's regulatory reforms and vision for America's financial dominance in the digital age.
Get the name of the ideal crypto for Trump's presidency for just $3 before his policies drive prices higher.
🔍 Market Analysis & Insights
James Cameron Warns of ‘Disastrous’ Potential of Netflix-WBD Deal in Fiery Letter to Lawmaker
The “Titanic” director tells Sen. Mike Lee the merger could turn the theater-going experience into a “sinking ship” The post James Cameron Warns of ‘Disastrous’ Potential of Netflix-WBD Deal in Fiery Letter to Lawmaker appeared first on TheWrap.
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces its financial results for the year ended December 31, 2025.
Why is Dow Jones down today: Dow crashes more than 270 points today – S&P 500 and Nasdaq also in deep red
Why is Dow Jones down today: Dow Jones Industrial Average dropped 271.87 points on Thursday, falling 0.55% to close at 49,390.79. The S&P 500 fell 0.37% to 6,855.89, while the Nasdaq Composite dropped 0.33% to 22,677.60. High crude oil prices and rising U.S.-…
Hyperliquid tests $30: Will a squeeze trigger HYPE’s breakout?
HYPE’s fundamentals strong, but will whale bets hold back a $30 breakout?
Republicans Risk ‘Devastating’ Midterm Turnout If Trump Admin Ignores Pro-Life Priorities, Poll Finds
Republicans risk a “devastating” midterm turnout if the Trump administration ignores pro-life priorities, a new poll found.
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO. Click here now for the urgent details on this hidden play.
💰 Investment Opportunities
Could EU Regulators Favor Paramount Over Netflix in Battle for Warner Bros. Discovery?
David Ellison’s heated battle with Netflix for ownership of Warner Bros. Discovery could wind up playing out prominently in Brussels, where regulatory officials are expected to formally open an antitrust probe as part of their approval procedure, once a deal …
Walmart To Report Results, Fresh Off New Highs, A New CEO And $1 Trillion Market Cap – Investor's Business Daily
Walmart To Report Results, Fresh Off New Highs, A New CEO And $1 Trillion Market CapInvestor's Business Daily Walmart will report earnings before the bell. Here's what to expectCNBC Walmart Offers Cautious Profit Forecast, Citing ‘Fluid’ BackdropBloomberg.com…
Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight
With several potential therapies, including Sepiapterin (PTC Therapeutics), NGGT002 (NGGT), JNT-517 (Jnana Therapeutics), Pegvaliase (BioMarin), and others under investigation, the phenylketonuria treatment landscape is expected to undergo substantial transfo…
In reversal, U.S. agrees to review new Moderna flu shot
Vaccine manufacturer Moderna said Wednesday the U.S. Food and Drug Administration walked back its previous position and agreed to review the company's new mRNA-based flu shot. Last week the U.S. firm said the federal vaccine regulator rejected the application…
FDA reverses course on Moderna flu shot
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.
Wall Street's Secret Crypto Accumulation Exposed
This protocol is fueling billions in transactions while most investors chase headlines… creating what could be the most asymmetric opportunity of 2025! Revealed: Get the name of Wall Street's favorite crypto for just $3 before it potentially skyrockets!